CDK12 can affect the c-myc/β-catenin pathway to stimulate papillary thyroid cancer proliferation and metastasis.CDK12 might be a new therapeutic target for papillary thyroid cancer. The gene discussed is MYC; the disease is thyroid gland papillary carcinoma.